COVID-19 Resources from JNCCN


JNCCN understands that a forum for sharing best practices and specific institutional responses relating to COVID-19 in the oncology ecosystem may be helpful to others. Therefore, we are publishing as expeditiously as possible documents and recommendations accepted by the JNCCN reviewers and editors as resources for oncology care providers. We will post more such articles as they become available; they may also appear in print editions of JNCCN as space allows. Please check back for additional updates.

Click here for additional resources from NCCN.


Incident Cancer Detection During the COVID-19 Pandemic

Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine

Cancer Treatment During COVID-19: Resilience of Individuals With Advanced Non–Small Cell Lung Cancer Versus Community Controls

COVID-19 and Cancer Center Operations: Lessons Learned From the NCCN Best Practices Committee

Impact of Telemedicine on Patient Satisfaction and Perceptions of Care Quality in Radiation Oncology

Outcomes of COVID-19 in Patients With a History of Cancer and Comorbid Cardiovascular Disease

Creative Strategies Implemented During the Coronavirus Pandemic That Will Impact the Future of Cancer Care

Experience, Perceptions, and Recommendations Concerning COVID-19–Related Clinical Research Adjustments

Telemedicine in Oncology and Reimbursement Policy During COVID-19 and Beyond

Considerations for Use of Hematopoietic Growth Factors in Patients With Cancer Related to the COVID-19 Pandemic

Safety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe

Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal

Commentary: Clinical Trials in the Age of Pandemics

Commentary: Interventions for Financial Toxicity: More Crucial Than Ever in the Time of COVID-19